And what about this company they partnered with to sell the
And what about this company they partnered with to sell the product in the VA hospitals? They stated while most are closed, some are opening up, so if they were working in the VA hospitals before, why were they not selling to these hospitals with this company or telling us they were and finally making revenue?
They received an investment, so excellagen should have been all over the map selling to open VA hospitals as well as others.
But silence……
We had previously launched Excellagen and in December of 2019 had ramped it up to over $500,000 in sales that month. Unfortunately, the Covid Pandemic hit and stopped our sales in its track as elective surgeries and new sales calls were shut down completely to the focused Sales Channel. We had signed an Agreement with AvMedical which has a national contract with the VA. This created more opportunity within the entire VA system. Excellagen is looked at as a best in class wound healing product. The FDA has authorized its use in 17 different indications, and we had already completed our tests within the VA and gained acceptance. Now, some of the major metropolitan VA centers are still closed to us, but many have reopened. We received an exclusive investment into the restart of revenues activities this week. The use of funds will be used to
1
Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...
Continue Reading
The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...
Continue Reading
IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...
Continue Reading
The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...
Continue Reading
Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...
Continue Reading
Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...
Continue Reading
A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...
Continue Reading
Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...
Continue Reading
Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...
Continue Reading
In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...
Continue Reading
Top 5 Most Recently Viewed Articles
Job Shortages: A Deeper Crisis for the U.S. Economy In recent discussions, Ford's CEO, Jim Farley, has raised alarming concerns regarding the growing labor shortage in important sectors of the U.S. economy. This situation is pressing— over 1 million jobs are currently unfilled in essential fields, from emergency services to skilled trades, indicating a silent crisis...
Continue Reading
Understanding Meta Platforms In today's fast-paced business landscape, a detailed analysis of companies is crucial for investors and market experts. This article focuses on Meta Platforms (NASDAQ: META), the world's premier social media entity, as we evaluate its performance alongside its key competitors in the Interactive Media & Services industry. By examining essential...
Continue Reading
authID Collaborates with ADIA to Enhance Digital Identity Solutions authID, a prominent provider in biometric identity verification, is set to make a significant impact on the way reusable digital identities are handled across the internet. By joining the Accountable Digital Identity Association (ADIA), authID aims to lead the charge in establishing global standards that...
Continue Reading
Overview of Syensqo's Share Buyback Program Syensqo SA, a leading science company, has made an important announcement regarding its Share Buyback Program following recent advancements. The initiative involves repurchasing up to 983,000 shares, which aims to boost value for shareholders. This move demonstrates the company's dedication to returning capital to its investors,...
Continue Reading
Firan Technology Group's 2024 Financial Overview Firan Technology Group Corporation (TSX: FTG, OTCQX: FTGFF) has announced its financial performance for 2024, showcasing remarkable growth and strategic initiatives aimed at enhancing shareholder value. This performance is a testament to the company’s commitment to operational excellence and proactive market engagement....
Continue Reading